Fasikl Incorporated
Fasikl is a Minneapolis-based neuro-AI company (spin-off from the University of Minnesota, founded 2019) developing cloud-connected AI therapeutics and neural-interface technologies. The company develops adaptive, real-time neurostimulation systems and implantable nerve-computer interfaces, supports multi-center clinical trials, and holds regulatory clearances and breakthrough designations for selected products.
Industries
Nr. of Employees
small (1-50)
Fasikl Incorporated
Minneapolis, Minnesota (company location referenced; no street address provided)
Products
Felix NeuroAI Wristband
A cloud-connected, noninvasive wearable that delivers closed-loop transcutaneous neurostimulation using adaptive AI to reduce upper-limb tremor related functional limitations in adults with essential tremor.
Fasikl-X Nerve-Computer Interface
Investigational/implantable peripheral nerve-computer interface designed to capture high-resolution neural signals for prosthetic control and to address post-amputation pain; has received FDA Breakthrough Device designation.
Felix NeuroAI Wristband
A cloud-connected, noninvasive wearable that delivers closed-loop transcutaneous neurostimulation using adaptive AI to reduce upper-limb tremor related functional limitations in adults with essential tremor.
Fasikl-X Nerve-Computer Interface
Investigational/implantable peripheral nerve-computer interface designed to capture high-resolution neural signals for prosthetic control and to address post-amputation pain; has received FDA Breakthrough Device designation.
Services
Cloud service that hosts adaptive AI models for continuous personalization and optimization of neuromodulation therapies.
Cloud service that hosts adaptive AI models for continuous personalization and optimization of neuromodulation therapies.
Expertise Areas
- Neuromodulation and wearable therapeutics
- Peripheral nerve interfacing and neural signal acquisition
- Clinical trial management and evidence generation for medical devices
- AI/ML model development for real-time therapeutic control
Key Technologies
- Cloud-based adaptive machine learning
- Closed-loop transcutaneous neurostimulation
- Peripheral nerve recording at fascicle/fiber resolution
- Embedded microelectronics for neural interfaces
News & Updates
CEO presented on AI therapeutics, NeuroAI algorithms, and microchip technologies and discussed future AI-driven medical devices.
Accepted into Google for Startups Cloud Program with $300,000 in Google Cloud credits to support AI development and infrastructure.
Publication reporting randomized clinical trial results showing significant improvements on modified Activities of Daily Living in essential tremor patients using the wearable AI therapy.
TRANQUIL trial results (randomized, double-blind, sham-controlled) demonstrating superiority of the AI-driven wristband over sham control presented at the American Academy of Neurology annual meeting.
U.S. Food and Drug Administration 510(k) clearance granted for the AI-powered wristband for tremor-related functional limitations in adults with essential tremor.
Peer-reviewed publication reporting clinical trial data showing improved daily function among essential tremor patients using the AI wristband.
CEO presented on AI therapeutics, NeuroAI algorithms, and microchip technologies and discussed future AI-driven medical devices.
Accepted into Google for Startups Cloud Program with $300,000 in Google Cloud credits to support AI development and infrastructure.
Publication reporting randomized clinical trial results showing significant improvements on modified Activities of Daily Living in essential tremor patients using the wearable AI therapy.
TRANQUIL trial results (randomized, double-blind, sham-controlled) demonstrating superiority of the AI-driven wristband over sham control presented at the American Academy of Neurology annual meeting.
U.S. Food and Drug Administration 510(k) clearance granted for the AI-powered wristband for tremor-related functional limitations in adults with essential tremor.
Peer-reviewed publication reporting clinical trial data showing improved daily function among essential tremor patients using the AI wristband.